Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 932 results for "astrazeneca"

Recruitment specialist Trialbee snags a deal with AstraZeneca

Trialbee, a Swedish patient-recruitment outfit, has added AstraZeneca( $AZN ) to its client roster, bringing its direct-to-patient technology to the U.K. drugmaker. Trialbee's platform allows sponsors to tap into online patient groups and scout for ... Fierce CRO, 11 hours ago
[x]  

250 images for astrazeneca

American Banking News, 21 hours ago
Yahoo! UK and Ireland, 2 days ago
Orlando Sentinel, 1 week ago
Yahoo! News, 1 week ago
Reuters, 1 week ago
4 Traders, 1 week ago
Hampton Roads Daily Press, 1 week ago
MSN Money Canada, 1 week ago
Fidelity Brokerage Services LLC, 1 week ago
Field Fisher Waterhouse, 2 days ago

Potential AstraZeneca (AZN) Trade Targets 6.62% Return

AstraZeneca Plc (http://www.marketintelligencecenter.com/symbol/AZN"AZN) was identified by MarketIntelligenceCenter.comaEUR(TM)s patented algorithms today after trading between $72.49 and $73.97 on Friday before closing at $73.30. A diagonal spread ...
 Individual.com5 hours ago AstraZeneca (AZN) Trading Near $72.83 Support Level  Individual.com6 days ago Potential AstraZeneca (AZN) Trade Has 8.03% Downside Protection  Individual.com1 week ago

AstraZeneca spotlights FluMist in campaign with Van Der Beek

WILMINGTON, Del. AstraZeneca has partnered with actor James Van Der Beek on a campaign to stress the importance of getting an annual flu vaccination and to address common myths about influenza. The drug maker said Monday that the effort also ...
 Chain Drug Review6 hours ago Actor And AstraZeneca PLC Join Forces To Educate Families About Influenza  BioSpace9 hours ago Actor James Van Der Beek and AstraZeneca Join Forces to Educate Families about Influenza  Wall Street Select13 hours ago James Van Der Beek is the celebrity face of AstraZeneca's flu campaign  UPI6 hours ago
[x]  

Barron's sees two good fits for Pfizer

Barron's Ben Levisohn believes that AstraZeneca ( AZN +0.7% ) remains a solid target for Pfizer ( PFE +0.9% ) citing the tax inversion appeal, the ability to free up its ex-U.S. cash and AZN's robust pipeline. He also believes Actavis ( ACT -0.2% ...
 Seeking Alpha9 hours ago
American Banking News

AstraZeneca plc Receives Neutral Rating from Zacks (AZN)

AstraZeneca plc (NYSE:AZN) Zacks analyst wrote, "AstraZeneca's second-quarter 2014 core earnings of $1.30 per ADS beat the Zacks Consensus Estimate of $1.13. Earnings were also up 13% (at CER) year over year. AstraZeneca's quarterly revenues ...
 American Banking News2 hours ago AstraZeneca plc Given Hold Rating at Panmure Gordon (AZN)  Mideast Time3 hours ago AstraZeneca plc Stock Rating Reaffirmed by Jefferies Group (AZN)  Mideast Time3 hours ago Jefferies Group Reiterates Hold Rating for AstraZeneca plc (AZN)  American Banking News13 hours ago
[x]  
Nasdaq

Benralizumab Phase II COPD Study

AstraZeneca recently announced that The Lancet Respiratory Medicine has published encouraging safety and efficacy data from a Phase IIa study evaluating its novel investigational monoclonal antibody benralizumab in patients with chronic obstructive ...
 Advance for Respiratory Care & Sleep Medicine19 hours ago Benralizumab Phase II COPD study published  Medical News Today4 days ago AstraZeneca Presents Unfavorable Benralizumab Study Data  Yahoo! Finance6 days ago Encouraging new data with AstraZeneca's benralizumab08-09-2014  Pharma Letter1 week ago
[x]  
Reuters

AstraZeneca joins sponsors of Silver Jubilee Business Awards

Global life sciences heavyweight AstraZeneca and its Cambridge subsidiary MedImmune have joined the A-list sponsors line-up for the 25th Anniversary Business
 Business Weekly UK1 hour ago Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors  Reuters1 week ago AstraZeneca boosted by start of new cancer drug trial  Reuters2 weeks ago AstraZeneca boosts lung drug business with Almirall deal  Economic Times1 month ago

Why AstraZeneca plc Should Beat The FTSE 100 This Year

Although the recovering FTSE 100 had a strong run in 2013 and turned in a gain of 14%, AstraZeneca (LSE:AZN) (NYSE: AZN.US) easily beat it with a 23% rise to end the year at close to £37 per share. So far in 2014, AstraZeneca shares are up another ...
 Interactive Investor12 hours ago

A Scottish Yes Can Boost ARM Holdings Plc, AstraZeneca plc, BHP Billiton plc, Diageo plc & GlaxoSmithKline plc

One big loser in the Scottish referendum debate is the pound. Sterling has fallen to a 10-month low as investors pull their money out of Britain ahead of next week's vote. It could fall another 15% next week if the Scots exit the union, according ...
 Yahoo! UK and Ireland3 days ago Is GlaxoSmithKline plc's Opportunity AstraZeneca plc's Threat?  Motley Fool UK4 days ago A Scottish 'Yes' Can Boost ARM Holdings Plc, AstraZeneca plc, BHP Billiton plc, Diageo plc & GlaxoSmithKline plc  Motley Fool UK3 days ago
Money Control

AstraZeneca Pharma's AGM on Sept 30, 2014

AstraZeneca Pharma India Ltd has informed BSE that the 35th Annual General Meeting (AGM) of the Company will be held on September 30, 2014.
 Money Control3 days ago AstraZeneca Pharma I - AGM on Sep 30, 2014  SBICAP Securities3 days ago Shares of AstraZeneca Under Pressure, Down 1.8%  Individual.com1 week ago Astrazeneca Pharma India to hold AGM  Business Standard2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - astrazeneca
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less